CNS safety pharmacology: psychoactive effects of mGluR5 antagonists AZD9272 and AZD2066
Michael D. B. Swedberg, Ph.D.
: June 17, 2014 10:30 AM |
: June 17, 2014 10:30 AM
Congratulations 2021 Incoming Board Members!
Updated 4:18PM EDT, Tue Oct 20th, 2020
We look forward to fulfilling the SPS Mission alongside you in 2021 and beyond.
SPS Announces 2020 Publication Award Recipients
Updated 6:57PM EDT, Fri Oct 9th, 2020
During our 2020 Virtual Annual Meeting, September 14-17, 2020, the Safety Pharmacology Society recognized the award recipients for our Translational Safety Pharmacology Publication Award and Technolog...
Webinar of Interest! Exploring safety issues in antimicrobial drug development
Updated 5:19PM EDT, Thu Oct 1st, 2020
This webinar was developed in collaboration with CARB-X, JPIAMR, REPAIR Impact Fund, Wellcome Trust, ASM and ESCMID. It is part of the ‘Antibiotic Bootcamps for Developers’ series which ha...
2020 The Safety Pharmacology Society. All Rights Reserved.
All material, files, logos and trademarks within this site are properties of their respective organizations.
Terms of Service